Bristol Myers Squibb (BMY) Q3 2024 Results

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, USA, on Wednesday, December 27, 2023.…

FDA approves Bristol Myers Squibb's schizophrenia drug

Bristol Myers Squibb's Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol-Myers SquibbCobenfy, the…

Stocks set to move as this corner of the cancer therapy market heats up

Much attention has been paid lately to a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy…